EUVIMEDEUVIMED entdecken
Leitlinie

Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines

Ibrahim Mian, Deloshaan Subhaharan, Adam Haig, Rupert Cox, Tariq Masood, Alicia Braund, Natalie Funakoshi

World Journal of Hepatology · 27.06.2026 · 18 (6)

DOI: 10.4254/wjh.117996 ↗

Kurz gefasst

Leitlinie in der Zeitschrift World Journal of Hepatology, online erschienen am 27.06.2026. Verfasst von Ibrahim Mian und 6 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Chronic hepatitis B (CHB) patients are at increased risk of developing hepatocellular carcinoma (HCC), however risk varies greatly between individuals. The Gastroenterological Society of Australia (GESA) consensus guidelines were developed to ensure patients receive appropriate surveillance; however, these guidelines do not account for other established risk factors. Various HCC risk scoring systems have been developed, including the Risk Estimation for HCC in CHB (REACH-B), modified REACH-B (mREACH-B) and Platelet Age Gender-Hepatitis B (PAGE-B) scores which have been validated in specific ethnic populations. AIM To evaluate differences in HCC surveillance patterns between current GESA recommendations and risk scoring tools for non-cirrhotic CHB patients. METHODS A prospectively collected health registry identified all patients with CHB from a regional tertiary Australian hospital in South East Queensland from 2019 to 2022. REACH-B, mREACH-B and PAGE-B scores were calculated for non-cirrhotic CHB patients. Surveillance patterns between scoring systems and current guidelines were compared. RESULTS A total of 314 patients were included. 35.0% (n = 110) were male, with a median age of 50.6 years. 69.7% of patients originated from Asia, 9.6% had a positive hepatitis B e-antigen status, and 37.9% were on antiviral therapy. Only 2 (0.6%) patients had progression to HCC. Using the GESA guidelines, 57% of patients qualified for HCC surveillance. However, when applying REACH-B, mREACH-B and PAGE-B scores, surveillance was recommended for 23.2%, 12.4% and 46.8% of patients respectively. This represented marked discordance between guideline-based and score-based surveillance eligibility. Notably, none of the scores identified the two patients who developed HCC as candidates for surveillance. All scores demonstrated poor discriminatory performance, with an area under the receiver operating characteristic curve of 0.53 for REACH-B, 0.55 for mREACH-B, and 0.39 for PAGE-B. CONCLUSION REACH-B, mREACH-B, and PAGE-B offer alternative options for risk stratification. However, this study suggests that the accuracy of these risk scores when applied to the Australian population may be limited, likely due to local virological, socio-demographic and lifestyle related factors which need to be taken into account. In heterogenous populations, these risk scores should be used cautiously and alongside individualized clinical assessment rather than as standalone decision tools.

Zitieren

APA

Mian, I., Subhaharan, D., Haig, A., Cox, R., Masood, T., Braund, A., & Funakoshi, N. (2026). Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines. World Journal of Hepatology, 18(6). https://doi.org/10.4254/wjh.117996

Vancouver

Mian I, Subhaharan D, Haig A, Cox R, Masood T, Braund A, et al. Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines. World Journal of Hepatology. 2026;18(6). doi:10.4254/wjh.117996

BibTeX
@article{Mian2026,
  author = {Mian, Ibrahim and Subhaharan, Deloshaan and Haig, Adam and Cox, Rupert and Masood, Tariq and Braund, Alicia and Funakoshi, Natalie},
  title = {Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines},
  journal = {World Journal of Hepatology},
  year = {2026},
  volume = {18},
  number = {6},
  doi = {10.4254/wjh.117996}
}
Kostenlos starten →